Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

NCT00752895

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States
  • Helen and Harry Gray Cancer Center at Hartford Hospital Hartford, Connecticut, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
View all 125 locations
View Trial Details
Completed

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02406742

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medical College Dr. Feldman's Office New York, United States
View all 24 locations
View Trial Details

Related conditions